Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 2,238

Document Document Title
WO/2007/058156A1
Disclosed is a novel tetracarboxylic acid compound having excellent characteristics such as high transparency, low dielectric property, low water absorption, low thermal expansion, solvent solubility and etching characteristics, while ex...  
WO/2006/134424A3
Methods and reagents for photo-initiated carbonylation with carbon-isotope labeled carbon monoxide using alkyl/aryl iodides with water pretreated by a base are provided. The resultant carbon-isotope labeled acids are useful as radiopharm...  
WO/2007/022263A1
The present invention relates to compounds useful for detecting the activity of human MCAD, compounds useful for competitively inhibiting human MCAD, as well as methods of manufacture thereof .  
WO/2007/002128A2
The invention relates to compositions and processes for producing novel hop acid formulations having improved bioavailability, and the use of such compositions as anti-inflammatory agents, dietary supplements, and pharmaceuticals.  
WO/2007/001940A2
The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled wit...  
WO/2007/001958A2
The radiolabeled non-natural amino acid 1-amino-3- cyclobutane-1-carboxylic acid (ACBC) and its analogs are candidate tumor imaging agents useful for positron emission tomography and single photon emission computed tomography due to thei...  
WO/2006/136471A1
The invention relates to a mixture of diisononyl esters of 1,2-cyclohexanedicarboxylic acid, characterized in that the isononyl radicals of the diisononyl esters contained in the mixture have a degree of branching of 1.2 to 2.0, to a met...  
WO2006087357A3
A new process is described, easy to perform on industrial scale, with high yield, for obtaining enantiomers of chrysanthemic acid starting from mixtures containing them. The process involves reacting said mixtures with enantiomers of 2- ...  
WO/2006/095355A1
The present invention relates to new salts or ion ion-pair complexes obtained by a reaction between boswellic acids or selectively enriched 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) or 11-keto-ß-boswellic acid (KBA) compounds obtained...  
WO/2006/087357A2
A new process is described, easy to perform on industrial scale, with high yield, for obtaining enantiomers of chrysanthemic acid starting from mixtures containing them. The process involves reacting said mixtures with enantiomers of 2- ...  
WO/2006/088025A1
Disclosed is a method for commercially advantageously producing a high-purity alicyclic monoolefin carboxylic acid with less impurities. Specifically disclosed is a method for producing a high-purity alicyclic monoolefin carboxylic acid ...  
WO2006065792A3
The present invention relates to non-psychoactive derivatives of tetrahydrocannabinol, which are useful in treating interstitial cystitis and relieving symptoms thereof. The invention uses cannabinol analogs, which are preferably analogs...  
WO/2006/066975A1
Process for the preparation of aryl or vinyl carboxylic acids via Pd-catalysed hydroxycarbonylation of aryl and vinyl bromides, wherein the aryl or vinyl bromides are reacted with a carbon monoxide source comprising lithium formate and a...  
WO/2006/063464A1
A process for preparing betulinic acid (3) comprising subjecting betulin (1) to an electrochemical oxidation reaction to provide a reaction product wherein a primary alcohol function of betulin (1) is converted to an aldehyde functionali...  
WO/2006/064179A1
There is provides a process for the preparation of a compound of formula (7): wherein R is an optionally substituted hydrocarbyl group or an optionally substituted heterocyclic group; provides that R is not a compound of Formula (a): whe...  
WO/2006/047329A2
A novel monomer composition is described. The novel monomer composition includes at least one property imparting unit. The property imparting unit has at least one member selected from the group consisting of conductivity imparting unit,...  
WO2005118564A3
One aspect of the present invention relates to methods for synthesizing milnacipran or congeners thereof Another aspect of the present invention relates to asymmetric methods for synthesizing enantiomerically enriched milnacipran or cong...  
WO/2006/043519A1
A process which comprises reacting a 1,2,3,4-cyclobutane- tetracarboxylic-1,2:3,4-dianhydride [1] with an alcohol [2] in the presence of an acid catalyst to obtain a compound [3], isomerizing the compound [3] with a base catalyst into a ...  
WO/2006/028776A1
A method for synthesizing compounds of the formula (I) where Cm is a fullerene having m carbon atoms and each R is independently -H or -R” COOH where R is alkyl having 1-20 carbon atoms, substituted alkyl having 1-20 carbon atoms, alke...  
WO/2006/022825A1
Various non-limiting embodiments disclosed herein related to photochromic materials comprising the reaction product of (a) at least one ring-opening cyclic monomer, and (b) a photochromic initiator. Other non-limiting embodiments related...  
WO/2006/009266A1
A selenium compound, a nitrogenous aromatic compound, and an acid are mixed together optionally in the presence of a solvent to obtain an oxidation catalyst composition. The oxidation catalyst composition obtained shows catalytic activit...  
WO/2006/006178A1
This invention relates to novel corosolic acid analogs of the formula I, wherein R1, R2, R3, R4 and R5 are as indicated below in each of said analogs: 1. R1 = COCH3, R2= R3=R4= H, R5= COOH or R1, =R3=R4= H, R2= COCH3,R5= COOH 2. RI= R2= ...  
WO/2006/002470A1
The present invention provides transition metal complexes of enantiomerically enriched compounds for use as catalysts in asymmetric transformations.  
WO/2006/001964A2
The present invention provides moronic acid derivatives of the general Formula (I) which have antiviral activity, along with compositions containing the same and methods of use thereof.  
WO/2005/123649A1
This invention relates to analogs of 3-0-Acetyl-11-Keto-b-Boswellic acid (AKBA) that exhibit 5-Lipoxigenase inhibitory properties. These compounds may be used in pharmaceutical compositions for therapeutic applications against a variety ...  
WO2005009104A3
The present invention is directed to hepatocyte nuclear factor 4a (HNF-4a) receptor modulator compounds. This invention is also directed to pharmaceutical compositions containing such compounds as well as methods of using such compounds ...  
WO/2005/123650A1
A novel fluorinated adamantane derivative. It is a compound represented by the formula AF(-COF)n, wherein AF means a fluorinated adamantane residue which is an n-valent group formed by removing n hydrogen atom(s) from adamantane (provide...  
WO/2005/118564A2
One aspect of the present invention relates to methods for synthesizing milnacipran or congeners thereof Another aspect of the present invention relates to asymmetric methods for synthesizing enantiomerically enriched milnacipran or cong...  
WO/2005/110963A1
The present invention relates to compounds having the general formula (I) with the definitions of RI-R3 given below, and/or a salt or ester thereof. Furthermore the invention relates to the use of said compounds as a medicament, preferab...  
WO2005084141A3
The present invention relates to a composition for the prevention and the treatment of cardiovascular disease containing extracts of T. nucifera or abietane diterpenoid compound or terpenoid compound isolated from the same as an effectiv...  
WO/2005/095321A1
Accordingly the present invention provides an improved and economical process for the isolation of oleanolic acid from the roots of Lantana camara, resulting in the isolation of oleanolic acid with 1% yield.  
WO/2005/084141A2
The present invention relates to a composition for the prevention and the treatment of cardiovascular disease containing extracts of T. nucifera or abietane diterpenoid compound or terpenoid compound isolated from the same as an effectiv...  
WO2005049589A3
Disclosed are novel compounds of formula (I), having hypolipidaemic and hypocholesterolemic properties, their tautomeric forms, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acce...  
WO2005047215A3
Processes for the preparation of certain [3.1.0] hexane derivatives which are useful as mGluR agonists, and intermediates prepared during such processes.  
WO/2005/051884A1
[MEANS FOR SOLVING PROBLEMS] A novel cyclic carboxylic acid formed by the addition reaction of an unsaturated carboxylic acid with a conjugated diene compound; a metal salt of the acid; a compounding agent (A) for antifouling coating com...  
WO/2005/049589A2
Disclosed are novel compounds of formula (I), having hypolipidaemic and hypocholesterolemic properties, their tautomeric forms, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acce...  
WO/2005/047215A2
Processes for the preparation of certain [3.1.0] hexane derivatives which are useful as mGluR agonists, and intermediates prepared during such processes.  
WO2004092145A8
Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R...  
WO2004093650A3
The present invention relates to novel modified fatty acid analogs, where a positron or gamma-emitting label is placed at a position on a fatty acid backbone and an organic substituent is substituted at the 2,3; 3,4; 4,5; 5,6 and other s...  
WO/2005/027891A1
An accelerator for initial insulin secretion which contains a triterpene represented by the following general formula (1) and/or a triterpene represented by the following general formula (2).[Chemical formula 1] [In the formulae, R1 is C...  
WO/2005/027892A1
An early insulin secretion promoter comprising corosolic acid and so on. By using this early insulin secretion promoter, insulin can be quickly secreted immediately after eating and, moreover, excessive insulin secretion can be inhibited...  
WO2005009330A3
The invention relates to a method of obtaining inhibitors of the type II dehydroquinase enzyme and the precursors thereof from (-)-quinic acid, the aforementioned compounds having a carboxycyclohexene structure. More specifically, the in...  
WO/2005/019151A1
The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator acti...  
WO/2005/014519A1
The invention relates to a process for the preparation of a substituted geminal difluoroalkane, wherein an oxime is converted to the gerninal difluoroalkane using a nitrite and a complex consisting of HF and an organic base, as well as i...  
WO/2005/009330A2
The invention relates to a method of obtaining inhibitors of the type II dehydroquinase enzyme and the precursors thereof from (-)-quinic acid, the aforementioned compounds having a carboxycyclohexene structure. More specifically, the in...  
WO2004091278A3
The present invention comprises an organic acid salt of gabapentin, wherein the organic acid is tartaric acid, ethanedisulfonic acid, or maleic acid. Methods for modulating the solubility and dose response of gabapentin are discussed. Me...  
WO/2005/009104A2
The present invention is directed to hepatocyte nuclear factor 4a (HNF-4a) receptor modulator compounds. This invention is also directed to pharmaceutical compositions containing such compounds as well as methods of using such compounds ...  
WO/2004/110973A1
The present invention discloses platinum (II) complexes with effective anticancer activity, characterized in that the new platinum (II) complexes are formed by reacting the anionic ligand of Camphoric radicals with the cationic ligand of...  
WO2004076349B1
Disclosed and claimed herein are e,e,e malonic acid/acetic acid tri-adduct of buckminsterfullerene of the general formula C60R3, wherein each R is independently selected from groups of the formula -CR<1>R<2> wherein each R<1> and R<2> is...  
WO/2004/093650A2
The present invention relates to novel modified fatty acid analogs, where a positron or gamma-emitting label is placed at a position on a fatty acid backbone and an organic substituent is substituted at the 2,3; 3,4; 4,5; 5,6 and other s...  

Matches 151 - 200 out of 2,238